IRS1 and Insulin resistance: In our model, we observed that treatment with high palmitate concentrations (0.5 mM for 24 h) inhibited insulin–stimulated GLP-1 secretion and induced a state of insulin resistance at the level of the IRS-1/AKT pathway.